@techcrunch.com 1 year ago
Visby Medical tests positive for a Series E extension at $1B+ valuation
@xconomy.com 4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology